Skip to main content
Livermore
Livermore
ZHEN

Alps Advisors Inc

SEC CIK
0001376113
Latest filing
Jul 29, 2026

RCUS holding history

Arcus Biosciences, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RCUS overviewAll 13F holders of RCUSFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of RCUS by Alps Advisors Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−52,624−100.0%Sold outHolders
Q3 202552,624$715.7K<0.1%−4,462−7.8%ReducedHolders
Q2 202557,086$464.7K<0.1%−20,021−26.0%ReducedHolders
Q1 202577,107$605.3K<0.1%+3,112+4.2%AddedHolders
Q4 202473,995$1.10M<0.1%+5,633+8.2%AddedHolders
Q3 202468,362$1.05M<0.1%−2,586−3.6%ReducedHolders
Q2 202470,948$1.08M<0.1%+6,858+10.7%AddedHolders
Q1 202464,090$1.21M<0.1%+11,619+22.1%AddedHolders
Q4 202352,471$1.00M<0.1%−2,480−4.5%ReducedHolders
Q3 202354,951$986.4K<0.1%+1,214+2.3%AddedHolders
Q2 202353,737$1.09M<0.1%+5,637+11.7%AddedHolders
Q1 202348,100$877.3K<0.1%−675−1.4%ReducedHolders
Q4 202248,775$1.01M<0.1%+9,400+23.9%AddedHolders
Q3 202239,375$1.03M<0.1%−3,174−7.5%ReducedHolders
Q2 202242,549$1.08M<0.1%−30,491−41.7%ReducedHolders
Q1 202273,040$2.31M<0.1%−8,255−10.2%ReducedHolders
Q4 202181,295$3.29M<0.1%−6,208−7.1%ReducedHolders
Q3 202187,503$3.05M<0.1%−6,003−6.4%ReducedHolders
Q2 202193,506$2.57M<0.1%−23,945−20.4%ReducedHolders
Q1 2021117,451$3.30M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.